A DNA prime-live vaccine boost strategy in mice can augment IFN-γ responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

Immunology

Volumn 108, Issue 4, 2003, Pages 548-555

  Skinner, M A ^a   Ramsay, A J ^b,c   Buchan, G S ^d   Keen, D L ^a   Ranasinghe, C ^c   Slobbe, L ^d   Collins, D M ^a   De Lisle, G W ^a   Buddle, B M ^a  

^a AGRESEARCH   (New Zealand)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; LIVE VACCINE; MYCOBACTERIUM ANTIGEN; PLASMID DNA;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; ATTENUATION; BACTERIAL STRAIN; CATTLE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; LUNG; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SPLEEN; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CATTLE; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; TUBERCULOSIS, BOVINE; VACCINES, ATTENUATED; VACCINES, DNA;

EID: 0344406062     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01589.x     Document Type: Article

References (39)

1. Skinner MA, Wedlock DN, Buddle BM. Vaccination of animals against Mycobacterium bovis. Rev sci tech Off int Epiz 2001; 20:112-32.
2. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45.
3. Buddle BM, Aldwell F, Wedlock DN. Vaccination of cattle and possums against bovine tuberculosis. In: Griffin F, de Lisle G, eds. Tuberculosis in Wildlife and Domestic Animals. Otago Conference Series no. 3. Dunedin, New Zealand: University of Otago Press, 1995:113-5.
4. Slobbe L, Lockhart E, O'Donnell M, Makintosh C, Buchan G. An in vitro comparison of BCG and cytokine secreting BCG vaccines. Immunology 1999; 96:517-23.
5. Baldwin SL, D'Souza C, Roberts AD et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun 1998; 66:2951-9.
6. Lowrie DB, Silva CL, Colston MJ, Ragno S, Tascon RE. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 1997; 15:834-8.
7. Buddle BM. Vaccination of cattle against Mycobacterium bovis. Tuberculosis 2002; 81:125-32.
8. Orme IM, McMurray DN, Belisle JT. Tuberculosis vaccine development: recent progress. Trends Micro 2001; 9:115-8.
9. Roberts AD, Sonnenberg MG, Ordway DL, Furney SK, Brennan PJ, Belisle T, Orme IM. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. J Immunol 1995; 85:502-8.
10. Bosio CM, Orme IM. Effective, nonsensitizing vaccination with culture filtrate proteins against Mycobacterium bovis infections in mice. Infect Immun 1998; 66:5048-51.
11. Brandt L, Elhay M, Rosenkrands I, Lindblad E, Andersen P. ESAT-6 subunit vaccination against. Mycobacterium tuberculosis Infect Immun 2000; 68:791-5.
12. de Lisle GW, Wilson T, Collins DM, Buddle BM. Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis. Infect Immun 1999; 67:2624-6.
13. Wedlock DN, Skinner MA, deLisle GW, Buddle BM. Control of Mycobacterium bovis infections and the risk to human population. Microbes Inf 2002; 4:471-80.
14. Wilsher ML, Hagan C, Prestidge R, Wells AU, Murison G. Human in vitro immune responses to Mycobacterium tuberculosis. Tuber Lung Dis 1999; 79:371-7.
15. Wedlock DN, Vesosky B, Skinner MA, de Lisle GW, Orme IM, Buddle BM. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis. Infect Immun 2000; 68:5809-15.
16. Hook S, Griffin F, Makintosh C, Buchan G. Activation of an interleukin-4 mRNA-producing population of peripheral blood mononuclear cells after infection with Mycobacterium bovis or vaccination with killed, but not live, BCG. Immunology 1996; 88:269-74.
17. Leal IS, Smedegard B, Andersen P, Appelberg R. Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation. Immunology 2001; 104:157-61.
18. Young S, O'Donnell M, Lockhart E, Buddle B, Slobbe L, Luo Y, De Lisle G, Buchan G. Manipulation of immune response to Mycobacterium bovis by vaccination with IL-2 and IL-18 secreting recombinant BCG. Immunol Cell Biol 2002; 80:209-15.
19. + T cells. Infect Immun 1987; 55:2037-41.
20. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992; 89:12013-7.
21. Ramshaw IA, Ramsay AJ. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 2000; 21:160-2.
22. Amara RR, Villinger F, Altman JD et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001; 292:69-74.
23. Shiver JW, Fu TM, Chen L et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002; 415:331-5.
24. Tanghe A, D'Souza S, Rosseels V, Denis O, Ottenhoff THM, Dalemans W, Wheeler C, Huygen K. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 2001; 69:3041-7.
25. + T-cell response and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun 2001; 69:681-6.
26. Feng CG, Palendira U, Demangel C, Spratt JM, Malin A, Britton W. Priming with DNA immunisation augments protective efficacy of Mycobacterium bovis Bacille-Calmette-Guerin against tuberculosis. Infect Immun 2001; 69:4174-6.
27. Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 2001; 69:2773-8.
28. Drew DR, Lightowlers M, Strugnell RA. Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Taenia ovis 45W antigen. Vaccine 2000; 18:2522-32.
29. Grover AA, Kim HK, Wiegeshaus EH, Smith DW. Host-parasite relationships in experimental airborne tuberculosis. II. Reprodncible infection by means of an inoculum preserved at -70° C. J Bacteriol 1967; 94:832-5.
30. Wiegeshaus EH, McMurray DN, Grover AA, Harding GE, Smith DW. Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs. Am Rev Respir Dis 1970; 102:422-9.
31. McMurray DN, Carlomagno MA, Mintzer CL, Tetzlaff CL. Mycobacterium bovis BCG vaccine fails to protect protein-deficient guinea pigs against respiratory challenge with virulent Mycobacterium tuberculosis. Infect Immun 1985; 50:555-9.
32. Buddle BM, deLisle GW, Pfeffer A, Aldwell FE. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 1995; 13:1123-30.
33. Buddle BM, Parlane NA, Keen DL, Aldwell FE, Pollock JM, Lightbody K, Andersen P. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. Clin Diag Lab Immunol 1999; 6:1-5.
34. Estcourt MJ, Ramsay AJ, Brooks A, Thomson SA, Medveckzy CJ, Ramshaw IA. Prime-boost immunization generates a high frequency, high-avidity CD8 (+) cytotoxic T lymphocyte population. Int Immunol 2002; 14:31-7.
35. Tange A, Denis O, Lambrecht B, Motte V, van den Berg T, Huygen K. Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infect Immun 2000; 68:3854-60.
36. Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, Appelberg R, Andersen P. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002; 70:672-8.
37. Wu CY, Kirman JR, Rotte MJ et al. Distinct lineages of T (H) 1 cells have differential capacities for memory cell generation in vivo. Nat Immunol 2002; 3:852-8.
38. Wang GZ, Balasubramanian V, Smith DW. The protective and allergenic potency of four BCG substrains in use in China determined in two animal models. Tubercle 1988; 69:283-91.
39. Buddle BM, Wards BJ, Aldwell FE, Collins DM, de Lisle GW. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 2002; 20:1126-33.